| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $116.1M | +5.6% | +13.5% |
| Cost of Revenue | $46.8M | +8.7% | +27.9% |
| R&D Expense | $47.9M | -5.3% | -27.4% |
| SG&A Expense | $70.1M | -1.3% | +4.3% |
| Operating Income | -$48.8M | +11.1% | +28.0% |
| Pre-tax Income | -$36.0M | +11.7% | +13.7% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $717.2M | -2.0% | +16.4% |
| Short-term Investments | $0 | — | — |
| Accounts Receivable | $85.4M | -3.5% | +70.9% |
| Inventory | $67.1M | +8.8% | +69.8% |
| Current Assets | $1.03B | -0.1% | +20.0% |
| Total Assets | $1.16B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$124.8M | — | — |
| Capital Expenditures | $7.4M | — | — |
| Investing Cash Flow | $319.2M | — | — |
| Financing Cash Flow | $72.8M | — | — |
| Free Cash Flow | -$132.2M | — | — |
| — |
| — |
| Net Income | -$36.0M | +11.7% | +13.7% |
| EPS (Basic) | -$0.03 | +25.0% | +25.0% |
| EPS (Diluted) | -$0.03 | +25.0% | +25.0% |
| -0.4% |
| +17.6% |
| Current Liabilities | $359.8M | +8.5% | +25.7% |
| Total Liabilities | $399.0M | +7.2% | +25.6% |
| Stockholders' Equity | $759.9M | -4.0% | +13.8% |